Spinal Muscular Atrophy: Pharmacotherapy – On Demand
This rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting is usually diagnosed in infancy or early childhood and if left untreated it is the most common genetic cause of infant death. The therapies available for this disorder will be explored along with the uniqueness of distribution of the therapies. Best Practices in therapy will be presented.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Explain the pathophysiology of SMA
- Discuss the place therapy for each of the three approved therapies
- Apply best practices to managing each therapy
Pharmacy technician learning objectives
- List the unique operational/distribution of each therapy
Additional Information
Attachment | Size |
---|---|
![]() | 134.66 KB |
On demand activity
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
The speakers will discuss investigative use of drugs.
Planning committee members
Jackie Stokes, BS
Manager, Pharmacy Program Services
Vizient, Inc.
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient, Inc.
Course reviewer
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient, Inc.
Presenters
Michael Storey, PharmD, MS
Medication Use Strategist
Nationwide Children's Hospital
James E. Dice, PharmD, BCPPS, FPPA
Clinical Pharmacy Specialist - P/T
Former Director of Pharmacy
Children's Hospital of The King's Daughters
![](https://continuingeducation.vizientinc.com/sites/default/files/Joint%20Accred%20LOGO.png)
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
____________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-21-177-H01-P
Universal Activity Number: JA0006103-0000-21-177-H01-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance